# Optimization of PK/PD Target Attainment for Ceftriaxone in Critically Ill Patients With Community-acquired Pneumonia.

> **NCT03438981** · — · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 30 (actual)

## Conditions studied

- Pharmacokinetics
- Critical Illness

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03438981
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2018-02
- **Final completion:** 2019-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03438981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03438981, "Optimization of PK/PD Target Attainment for Ceftriaxone in Critically Ill Patients With Community-acquired Pneumonia.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03438981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*